Soumare, Harouna M.
Guelbeogo, Wamdaogo Moussa
van de Vegte-Bolmer, Marga
van Gemert, Geert-Jan
Soumanaba, Zongo
Ouedraogo, Alphonse
Ouattara, Maurice S.
Abdullahi, Ahmad
Jadama, Lamin
Camara, Muhammed M.
Gaye, Pa Modou
Mendy, Michael
Davis, Nwakanma
Tiono, Alfred B.
D’Alessandro, Umberto
Drakeley, Chris
Bousema, Teun
Moreno, Marta
Collins, Katharine A. http://orcid.org/0000-0002-7080-2215
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1173572)
European Research Council (ERC-2019-CoG864180)
Medical Research Council and Department for International Development (MR/P02016X/1)
Article History
Received: 11 January 2021
Accepted: 4 April 2021
First Online: 20 April 2021
Declarations
:
: Data within this manuscript was generated using blood samples from clinical trial participants. In Burkina Faso, the participants were enrolled in a clinical trial that was reviewed and approved by the LSHTM ethics committee (Review number: 14724), the CNRFP institutional review board (Deliberation N° 2018/000002/MS/SG/CNRFP/CIB) and the Ethics Committee for Health Research in Burkina Faso (Deliberation N° 2018-01-010). The Gambia protocol was approved by the LSHTM ethics committee (Review number:15993) and The Gambia Government/MRC Joint Ethics Committee (Review number: 1621) . All participants gave informed consent before inclusion in the studies. .
: Not applicable.
: The authors declare that they have no competing interests.